VANCOUVER, BC — AbCellera (Nasdaq: ABCL) today announced a presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, to be held virtually and at the Boston Convention &… Read More
UBC faculty of medicine researchers received $11.1 million for two new projects to advance mRNA vaccine technologies and boost the impact of B.C. biotechnology on the global stage. The Honourable Harjit S…. Read More
VANCOUVER, MONTREAL, and TORONTO – adMare BioInnovations (adMare) is pleased to announce that 22 participants representing a wide range of life sciences enterprises from across the country were selected to… Read More
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2. These patients with HER2 low status may now be eligible for a targeted treatment, which… Read More
OTTAWA, ON – BioTalent Canada today announced that its recently launched I.D.E.A.L. Bioscience EmployerTM recognition program is now accepting applications. This new employer recognition program, which represents Inclusivity, Diversity, Equity, and… Read More
